img

Global Dengue Fever Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dengue Fever Treatment Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Dengue Fever Treatment market is projected to reach US$ 155.6 million in 2029, increasing from US$ 137 million in 2022, with the CAGR of 0.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dengue Fever Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dengue Fever Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Fresenius Kabi USA
Sun Pharmaceutical Industries
Mylan N.V
Pfizer
Teva Pharmaceuticals USA
EMERGEX VACCINES
Hikma Pharmaceuticals
ABIVAX, Aurobindo Pharma
Baxter
Perrigo
GlaxoSmithKline
Dr. Reddy’s Laboratories
Sanofi
Takeda Pharmaceutical
Segment by Type
Drug
Vaccines

Segment by Application


Hospital
Homecare
Specialty Clinics
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dengue Fever Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dengue Fever Treatment Market Overview
1.1 Product Overview and Scope of Dengue Fever Treatment
1.2 Dengue Fever Treatment Segment by Type
1.2.1 Global Dengue Fever Treatment Market Value Comparison by Type (2024-2034)
1.2.2 Drug
1.2.3 Vaccines
1.3 Dengue Fever Treatment Segment by Application
1.3.1 Global Dengue Fever Treatment Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Dengue Fever Treatment Market Size Estimates and Forecasts
1.4.1 Global Dengue Fever Treatment Revenue 2018-2029
1.4.2 Global Dengue Fever Treatment Sales 2018-2029
1.4.3 Global Dengue Fever Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dengue Fever Treatment Market Competition by Manufacturers
2.1 Global Dengue Fever Treatment Sales Market Share by Manufacturers (2018-2024)
2.2 Global Dengue Fever Treatment Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Dengue Fever Treatment Average Price by Manufacturers (2018-2024)
2.4 Global Dengue Fever Treatment Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Dengue Fever Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dengue Fever Treatment, Product Type & Application
2.7 Dengue Fever Treatment Market Competitive Situation and Trends
2.7.1 Dengue Fever Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dengue Fever Treatment Players Market Share by Revenue
2.7.3 Global Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dengue Fever Treatment Retrospective Market Scenario by Region
3.1 Global Dengue Fever Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dengue Fever Treatment Global Dengue Fever Treatment Sales by Region: 2018-2029
3.2.1 Global Dengue Fever Treatment Sales by Region: 2018-2024
3.2.2 Global Dengue Fever Treatment Sales by Region: 2024-2029
3.3 Global Dengue Fever Treatment Global Dengue Fever Treatment Revenue by Region: 2018-2029
3.3.1 Global Dengue Fever Treatment Revenue by Region: 2018-2024
3.3.2 Global Dengue Fever Treatment Revenue by Region: 2024-2029
3.4 North America Dengue Fever Treatment Market Facts & Figures by Country
3.4.1 North America Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dengue Fever Treatment Sales by Country (2018-2029)
3.4.3 North America Dengue Fever Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dengue Fever Treatment Market Facts & Figures by Country
3.5.1 Europe Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dengue Fever Treatment Sales by Country (2018-2029)
3.5.3 Europe Dengue Fever Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dengue Fever Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dengue Fever Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Dengue Fever Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dengue Fever Treatment Market Facts & Figures by Country
3.7.1 Latin America Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dengue Fever Treatment Sales by Country (2018-2029)
3.7.3 Latin America Dengue Fever Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dengue Fever Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dengue Fever Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dengue Fever Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dengue Fever Treatment Sales by Type (2018-2029)
4.1.1 Global Dengue Fever Treatment Sales by Type (2018-2024)
4.1.2 Global Dengue Fever Treatment Sales by Type (2024-2029)
4.1.3 Global Dengue Fever Treatment Sales Market Share by Type (2018-2029)
4.2 Global Dengue Fever Treatment Revenue by Type (2018-2029)
4.2.1 Global Dengue Fever Treatment Revenue by Type (2018-2024)
4.2.2 Global Dengue Fever Treatment Revenue by Type (2024-2029)
4.2.3 Global Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Dengue Fever Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dengue Fever Treatment Sales by Application (2018-2029)
5.1.1 Global Dengue Fever Treatment Sales by Application (2018-2024)
5.1.2 Global Dengue Fever Treatment Sales by Application (2024-2029)
5.1.3 Global Dengue Fever Treatment Sales Market Share by Application (2018-2029)
5.2 Global Dengue Fever Treatment Revenue by Application (2018-2029)
5.2.1 Global Dengue Fever Treatment Revenue by Application (2018-2024)
5.2.2 Global Dengue Fever Treatment Revenue by Application (2024-2029)
5.2.3 Global Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Dengue Fever Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Fresenius Kabi USA
6.1.1 Fresenius Kabi USA Corporation Information
6.1.2 Fresenius Kabi USA Description and Business Overview
6.1.3 Fresenius Kabi USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Fresenius Kabi USA Dengue Fever Treatment Product Portfolio
6.1.5 Fresenius Kabi USA Recent Developments/Updates
6.2 Sun Pharmaceutical Industries
6.2.1 Sun Pharmaceutical Industries Corporation Information
6.2.2 Sun Pharmaceutical Industries Description and Business Overview
6.2.3 Sun Pharmaceutical Industries Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sun Pharmaceutical Industries Dengue Fever Treatment Product Portfolio
6.2.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.3 Mylan N.V
6.3.1 Mylan N.V Corporation Information
6.3.2 Mylan N.V Description and Business Overview
6.3.3 Mylan N.V Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Mylan N.V Dengue Fever Treatment Product Portfolio
6.3.5 Mylan N.V Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Dengue Fever Treatment Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Teva Pharmaceuticals USA
6.5.1 Teva Pharmaceuticals USA Corporation Information
6.5.2 Teva Pharmaceuticals USA Description and Business Overview
6.5.3 Teva Pharmaceuticals USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Teva Pharmaceuticals USA Dengue Fever Treatment Product Portfolio
6.5.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.6 EMERGEX VACCINES
6.6.1 EMERGEX VACCINES Corporation Information
6.6.2 EMERGEX VACCINES Description and Business Overview
6.6.3 EMERGEX VACCINES Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.6.4 EMERGEX VACCINES Dengue Fever Treatment Product Portfolio
6.6.5 EMERGEX VACCINES Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hikma Pharmaceuticals Dengue Fever Treatment Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 ABIVAX, Aurobindo Pharma
6.8.1 ABIVAX, Aurobindo Pharma Corporation Information
6.8.2 ABIVAX, Aurobindo Pharma Description and Business Overview
6.8.3 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.8.4 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Portfolio
6.8.5 ABIVAX, Aurobindo Pharma Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Baxter Dengue Fever Treatment Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Perrigo
6.10.1 Perrigo Corporation Information
6.10.2 Perrigo Description and Business Overview
6.10.3 Perrigo Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Perrigo Dengue Fever Treatment Product Portfolio
6.10.5 Perrigo Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Dengue Fever Treatment Description and Business Overview
6.11.3 GlaxoSmithKline Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.11.4 GlaxoSmithKline Dengue Fever Treatment Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Dr. Reddy’s Laboratories
6.12.1 Dr. Reddy’s Laboratories Corporation Information
6.12.2 Dr. Reddy’s Laboratories Dengue Fever Treatment Description and Business Overview
6.12.3 Dr. Reddy’s Laboratories Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Dr. Reddy’s Laboratories Dengue Fever Treatment Product Portfolio
6.12.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Dengue Fever Treatment Description and Business Overview
6.13.3 Sanofi Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Sanofi Dengue Fever Treatment Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Takeda Pharmaceutical
6.14.1 Takeda Pharmaceutical Corporation Information
6.14.2 Takeda Pharmaceutical Dengue Fever Treatment Description and Business Overview
6.14.3 Takeda Pharmaceutical Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Takeda Pharmaceutical Dengue Fever Treatment Product Portfolio
6.14.5 Takeda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dengue Fever Treatment Industry Chain Analysis
7.2 Dengue Fever Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dengue Fever Treatment Production Mode & Process
7.4 Dengue Fever Treatment Sales and Marketing
7.4.1 Dengue Fever Treatment Sales Channels
7.4.2 Dengue Fever Treatment Distributors
7.5 Dengue Fever Treatment Customers
8 Dengue Fever Treatment Market Dynamics
8.1 Dengue Fever Treatment Industry Trends
8.2 Dengue Fever Treatment Market Drivers
8.3 Dengue Fever Treatment Market Challenges
8.4 Dengue Fever Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dengue Fever Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dengue Fever Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dengue Fever Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dengue Fever Treatment Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Dengue Fever Treatment Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Dengue Fever Treatment Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Dengue Fever Treatment Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Dengue Fever Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Dengue Fever Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Dengue Fever Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dengue Fever Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Dengue Fever Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dengue Fever Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Fever Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dengue Fever Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Dengue Fever Treatment Sales by Region (2018-2024) & (K Units)
Table 18. Global Dengue Fever Treatment Sales Market Share by Region (2018-2024)
Table 19. Global Dengue Fever Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Dengue Fever Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Dengue Fever Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Dengue Fever Treatment Revenue Market Share by Region (2018-2024)
Table 23. Global Dengue Fever Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Dengue Fever Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 27. North America Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 32. Europe Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Dengue Fever Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Dengue Fever Treatment Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Dengue Fever Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Dengue Fever Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Dengue Fever Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Dengue Fever Treatment Sales (K Units) by Type (2018-2024)
Table 51. Global Dengue Fever Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Dengue Fever Treatment Sales Market Share by Type (2018-2024)
Table 53. Global Dengue Fever Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Dengue Fever Treatment Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Dengue Fever Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Dengue Fever Treatment Revenue Market Share by Type (2018-2024)
Table 57. Global Dengue Fever Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Dengue Fever Treatment Price (US$/Unit) by Type (2018-2024)
Table 59. Global Dengue Fever Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Dengue Fever Treatment Sales (K Units) by Application (2018-2024)
Table 61. Global Dengue Fever Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Dengue Fever Treatment Sales Market Share by Application (2018-2024)
Table 63. Global Dengue Fever Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Dengue Fever Treatment Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Dengue Fever Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Dengue Fever Treatment Revenue Market Share by Application (2018-2024)
Table 67. Global Dengue Fever Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Dengue Fever Treatment Price (US$/Unit) by Application (2018-2024)
Table 69. Global Dengue Fever Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Fresenius Kabi USA Corporation Information
Table 71. Fresenius Kabi USA Description and Business Overview
Table 72. Fresenius Kabi USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Fresenius Kabi USA Dengue Fever Treatment Product
Table 74. Fresenius Kabi USA Recent Developments/Updates
Table 75. Sun Pharmaceutical Industries Corporation Information
Table 76. Sun Pharmaceutical Industries Description and Business Overview
Table 77. Sun Pharmaceutical Industries Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sun Pharmaceutical Industries Dengue Fever Treatment Product
Table 79. Sun Pharmaceutical Industries Recent Developments/Updates
Table 80. Mylan N.V Corporation Information
Table 81. Mylan N.V Description and Business Overview
Table 82. Mylan N.V Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Mylan N.V Dengue Fever Treatment Product
Table 84. Mylan N.V Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Dengue Fever Treatment Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Teva Pharmaceuticals USA Corporation Information
Table 91. Teva Pharmaceuticals USA Description and Business Overview
Table 92. Teva Pharmaceuticals USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Teva Pharmaceuticals USA Dengue Fever Treatment Product
Table 94. Teva Pharmaceuticals USA Recent Developments/Updates
Table 95. EMERGEX VACCINES Corporation Information
Table 96. EMERGEX VACCINES Description and Business Overview
Table 97. EMERGEX VACCINES Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. EMERGEX VACCINES Dengue Fever Treatment Product
Table 99. EMERGEX VACCINES Recent Developments/Updates
Table 100. Hikma Pharmaceuticals Corporation Information
Table 101. Hikma Pharmaceuticals Description and Business Overview
Table 102. Hikma Pharmaceuticals Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Hikma Pharmaceuticals Dengue Fever Treatment Product
Table 104. Hikma Pharmaceuticals Recent Developments/Updates
Table 105. ABIVAX, Aurobindo Pharma Corporation Information
Table 106. ABIVAX, Aurobindo Pharma Description and Business Overview
Table 107. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product
Table 109. ABIVAX, Aurobindo Pharma Recent Developments/Updates
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Baxter Dengue Fever Treatment Product
Table 114. Baxter Recent Developments/Updates
Table 115. Perrigo Corporation Information
Table 116. Perrigo Description and Business Overview
Table 117. Perrigo Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Perrigo Dengue Fever Treatment Product
Table 119. Perrigo Recent Developments/Updates
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Description and Business Overview
Table 122. GlaxoSmithKline Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. GlaxoSmithKline Dengue Fever Treatment Product
Table 124. GlaxoSmithKline Recent Developments/Updates
Table 125. Dr. Reddy’s Laboratories Corporation Information
Table 126. Dr. Reddy’s Laboratories Description and Business Overview
Table 127. Dr. Reddy’s Laboratories Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Dr. Reddy’s Laboratories Dengue Fever Treatment Product
Table 129. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Sanofi Dengue Fever Treatment Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Takeda Pharmaceutical Corporation Information
Table 136. Takeda Pharmaceutical Description and Business Overview
Table 137. Takeda Pharmaceutical Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Takeda Pharmaceutical Dengue Fever Treatment Product
Table 139. Takeda Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Dengue Fever Treatment Distributors List
Table 143. Dengue Fever Treatment Customers List
Table 144. Dengue Fever Treatment Market Trends
Table 145. Dengue Fever Treatment Market Drivers
Table 146. Dengue Fever Treatment Market Challenges
Table 147. Dengue Fever Treatment Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dengue Fever Treatment
Figure 2. Global Dengue Fever Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dengue Fever Treatment Market Share by Type in 2022 & 2029
Figure 4. Drug Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global Dengue Fever Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Dengue Fever Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Homecare
Figure 10. Specialty Clinics
Figure 11. Others
Figure 12. Global Dengue Fever Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dengue Fever Treatment Market Size (2018-2029) & (US$ Million)
Figure 14. Global Dengue Fever Treatment Sales (2018-2029) & (K Units)
Figure 15. Global Dengue Fever Treatment Average Price (US$/Unit) & (2018-2029)
Figure 16. Dengue Fever Treatment Report Years Considered
Figure 17. Dengue Fever Treatment Sales Share by Manufacturers in 2022
Figure 18. Global Dengue Fever Treatment Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Dengue Fever Treatment Players: Market Share by Revenue in 2022
Figure 20. Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Dengue Fever Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Dengue Fever Treatment Sales Market Share by Country (2018-2029)
Figure 23. North America Dengue Fever Treatment Revenue Market Share by Country (2018-2029)
Figure 24. United States Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Dengue Fever Treatment Sales Market Share by Country (2018-2029)
Figure 27. Europe Dengue Fever Treatment Revenue Market Share by Country (2018-2029)
Figure 28. Germany Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Dengue Fever Treatment Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Dengue Fever Treatment Revenue Market Share by Region (2018-2029)
Figure 35. China Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Dengue Fever Treatment Sales Market Share by Country (2018-2029)
Figure 43. Latin America Dengue Fever Treatment Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Dengue Fever Treatment Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Dengue Fever Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Dengue Fever Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Dengue Fever Treatment by Type (2018-2029)
Figure 53. Global Revenue Market Share of Dengue Fever Treatment by Type (2018-2029)
Figure 54. Global Dengue Fever Treatment Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Dengue Fever Treatment by Application (2018-2029)
Figure 56. Global Revenue Market Share of Dengue Fever Treatment by Application (2018-2029)
Figure 57. Global Dengue Fever Treatment Price (US$/Unit) by Application (2018-2029)
Figure 58. Dengue Fever Treatment Value Chain
Figure 59. Dengue Fever Treatment Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries